Global Diabetes Medicine Use by Country

In 2024, Finland leads global diabetes medicine use with 111.9 units per thousand persons per day, followed by Germany at 97.8 units, and Slovenia at 96.0 units. Countries with notable year-on-year increases in 2023 include Chile (11.86%), Norway (9.28%), and the United Kingdom (4.58%). Conversely, Luxembourg saw a slight decline of 0.99%, with New Zealand showing no change.

Finland, Germany, and Slovenia exhibit consistent usage trends, while emerging markets like Chile and Norway show significant growth. Countries like Norway, the United Kingdom, and Chile demonstrate above-average increases, indicating a rising need for diabetes medication. Luxembourg is the only country with a reduction in usage, potentially signaling effective diabetes management or alternative treatment methods.

Future trends to watch include technological advancements in diabetes management, the impact of healthcare policies on medication accessibility, and the potential increase in diabetes prevalence due to lifestyle changes. Emerging markets may continue to see significant growth, indicating a global shift in the focus towards diabetes care and management.